A Q3 2023 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q3 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B-2.7% YoY

Gross Profit

$658M39.4% margin

Operating Income

$133M8.0% margin

Net Income

$111M6.6% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

-2.6%

Cash Flow

Operating Cash Flow

$562M

Free Cash Flow

$481M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$10.7B

Total Liabilities

$5.1B

Stockholders' Equity

$5.6B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.7B	-2.7%
Gross Profit	$658M	$939M	-29.9%
Operating Income	$133M	$411M	-67.6%
Net Income	$111M	$329M	-66.3%

Revenue Segments

Life Sciences and Applied Markets

$927M55%

Agilent CrossLab

$396M24%

Diagnostics and Genomics

$349M21%

Geographic Segments

Americas

$667M40%

Asia Pacific

$573M34%

Europe

$432M26%